Harvard Apparatus Regenerative Technology, Inc. (NASDAQ: HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will announce results of its fourth quarter and year ended December 31, 2013 before market trading hours on Friday, March 7, 2014. A conference call to discuss the company’s fourth quarter and year-end results is scheduled for that same day at 11:00 AM (Eastern Time).
Help employers find you! Check out all the jobs and post your resume.
